An antimicrobial therapy kills or hinders the growth of microbes like bacteria, fungi, or protozoans. Therapies that kill microbes are called microbiocidal therapies and therapies that only inhibit the growth of microorganisms are called microbiostatic therapies. It contributes significantly to the quality of life of many people and reduces the morbidity and mortality due to infectious disease.
Antimicrobial peptides or proteins (AMPs) are a distinct class of naturally occurring particles that are produced as a first line of defence by all multicellular organisms. These proteins can have wide activity to directly destroy/kill bacteria, yeasts, fungi, viruses and even cancer cells. These peptides/proteins are potent, wide-ranging spectrum antibiotics which proves the potential as novel therapeutic agents.
Related: Antibiotics Conference, Antimicrobial Resistance Congress, Antibiotics Meetings, Antibiotics Event, Drug Resistance Congress, Antibiotic Resistance, Antimicrobial Event, Antibiotics Summit, Antimicrobial Resistance Conference.
Related Conferences: 2nd International Conference on Antimicrobial and Antibacterial Agents on November 11-12, 2019 Istanbul,Turkey; 14th World Congress on Infection Prevention and Control on December 6-7, 2018 at Valencia, Spain; 5th International Conference on Antibiotics & Antibiotic Resistance on May 30-31, 2019 Orlando, Florida,USA.
Related Associations: Alliance for the Prudent Use of Antibiotics, Global Antibiotic Resistance Partnership, Infectious Diseases Society of America, Antibiotic Research UK, The World Alliance Against Antibiotic Resistance, Australian Society of Antimicrobials, Centers for Disease Control and Prevention and Chinese Society for Microbiology.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
